1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Infectious Testing
1.2.3 Diabetes Testing
1.2.4 Molecular Testing
1.2.5 Tissue Testing
1.3 Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostic Services Market Perspective (2017-2028)
2.2 In-vitro Diagnostic Services Growth Trends by Region
2.2.1 In-vitro Diagnostic Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In-vitro Diagnostic Services Historic Market Size by Region (2017-2022)
2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Region (2023-2028)
2.3 In-vitro Diagnostic Services Market Dynamics
2.3.1 In-vitro Diagnostic Services Industry Trends
2.3.2 In-vitro Diagnostic Services Market Drivers
2.3.3 In-vitro Diagnostic Services Market Challenges
2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Diagnostic Services Players by Revenue
3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2017-2022)
3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2017-2022)
3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2021
3.5 In-vitro Diagnostic Services Key Players Head office and Area Served
3.6 Key Players In-vitro Diagnostic Services Product Solution and Service
3.7 Date of Enter into In-vitro Diagnostic Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2017-2022)
4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2023-2028)
5 In-vitro Diagnostic Services Breakdown Data by Application
5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2017-2022)
5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In-vitro Diagnostic Services Market Size (2017-2028)
6.2 North America In-vitro Diagnostic Services Market Size by Country (2017-2022)
6.3 North America In-vitro Diagnostic Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size (2017-2028)
7.2 Europe In-vitro Diagnostic Services Market Size by Country (2017-2022)
7.3 Europe In-vitro Diagnostic Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostic Services Market Size (2017-2028)
8.2 Asia-Pacific In-vitro Diagnostic Services Market Size by Country (2017-2022)
8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America In-vitro Diagnostic Services Market Size (2017-2028)
9.2 Latin America In-vitro Diagnostic Services Market Size by Country (2017-2022)
9.3 Latin America In-vitro Diagnostic Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostic Services Market Size (2017-2028)
10.2 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2017-2022)
10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioRad
11.1.1 BioRad Company Detail
11.1.2 BioRad Business Overview
11.1.3 BioRad In-vitro Diagnostic Services Introduction
11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.1.5 BioRad Recent Development
11.2 DexCom
11.2.1 DexCom Company Detail
11.2.2 DexCom Business Overview
11.2.3 DexCom In-vitro Diagnostic Services Introduction
11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.2.5 DexCom Recent Development
11.3 Nova Biomedical
11.3.1 Nova Biomedical Company Detail
11.3.2 Nova Biomedical Business Overview
11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.3.5 Nova Biomedical Recent Development
11.4 OraSure
11.4.1 OraSure Company Detail
11.4.2 OraSure Business Overview
11.4.3 OraSure In-vitro Diagnostic Services Introduction
11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.4.5 OraSure Recent Development
11.5 Pearl Pathways
11.5.1 Pearl Pathways Company Detail
11.5.2 Pearl Pathways Business Overview
11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.5.5 Pearl Pathways Recent Development
11.6 Phenomenex
11.6.1 Phenomenex Company Detail
11.6.2 Phenomenex Business Overview
11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.6.5 Phenomenex Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen In-vitro Diagnostic Services Introduction
11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.7.5 Qiagen Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Detail
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.8.5 Roche Diagnostics Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens In-vitro Diagnostic Services Introduction
11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-vitro Diagnostic Services Introduction
11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.10.5 Sysmex Recent Development
11.11 Thermofisher
11.11.1 Thermofisher Company Detail
11.11.2 Thermofisher Business Overview
11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2017-2022)
11.11.5 Thermofisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
